Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Cited by (1,001)

Items 601–700 of 1,001

1. The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications
   Joshua I. Barzilay, Barry R. Davis, Sara Pressel, Alokananda Ghosh, Mahboob Rahman, Paula T. Einhorn, William C. Cushman, Paul Kieran Whelton, Jackson T. Wright · 2018 · American Journal of Hypertension
2. Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin indb/dbdiabetic mice
   Laale F. Alawi, Sana E. Emberesh, Brenda A. Owuor, Harshita Chodavarapu, Rucha Fadnavis, Salim S. El‐Amouri, Khalid M. Elased · 2020 · Physiological Reports
3. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID‐19: A multicenter nationwide controlled study
   Savaş Öztürk, Kenan Turgutalp, Mustafa Arıcı, Mahmut Gök, Mahmud İslam, Mehmet Rıza Altıparmak, Zeki Aydın, Barış Döner, Necmi Eren, Erkan Şengül et al. · 2021 · International Journal of Clinical Practice
4. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study
   Edoardo Biancalana, Martina Chiriacò, Paolo Sciarrone, Alessandro Mengozzi, Sandra Mechelli, Stefano Taddei, Anna Solini · 2021 · Clinical Interventions in Aging
5. Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1
   Wei Deng, Dan Huang, Hongwu Xie, Limin Wang, Qun Shen, RongRong Zeng, YuanLian Huang, Jianhua Li, Bo Yang · 2022 · Bioengineered
6. Importance of high-density lipoprotein quality
   Valentina Kon, Talat Alp Ikizler, Sergio Fazio · 2013 · Current Opinion in Nephrology & Hypertension
7. Physical Activity and Risk of Colon Cancer in Diabetic and Nondiabetic US Adults
   Daniela Schmid, Gundula Behrens, Charles Edwards Matthews, Michael Fred Leitzmann · 2016 · Mayo Clinic Proceedings
8. Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife
   H. Kramer, L. Colangelo, C. Lewis, D. Jacobs, M. Pletcher, Kirstin Bibbins-Domingo, Alex R. Chang, D. Siscovick, M. Shlipak, C. Peralta et al. · 2017 · American Journal of Hypertension
9. Chronic Kidney Disease is Associated with Intracranial Artery Stenosis Distribution in the Middle-Aged and Elderly Population
   Xiaowei Song, Jun Li, Hua Yang, Chunxiu Wang, Beibei Liu, Chunxiao Liu, Qiannan Zhao, Zhongying Zhang, Xianghua Fang, Jian Wu · 2019 · Journal of Atherosclerosis and Thrombosis
10. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients
    Tanaka, Nobue, Babazono, Tetsuya, Takagi, Michino, Yoshida, Naoshi, Toya, Kiwako, Nyumura, Izumi, Hanai, Ko, Uchigata, Yasuko · 2015 · Nephrology
11. Proteinuria, measured or estimated albuminuria for risk prediction in patients with chronic kidney disease?
    Hyoungnae Kim, Young Youl Hyun, Young Su Joo, Hae‐Ryong Yun, Yaeni Kim, Ji Yong Jung, Jong Cheol Jeong, Jayoun Kim, Jung Tak Park, Tae‐Hyun Yoo et al. · 2023 · Nephrology Dialysis Transplantation
12. Role of Diabetes Self-management Education for Our Health Systems and Economy
    Betül Hatipoğlu, Peter J. Pronovost · 2025 · The Journal of Clinical Endocrinology & Metabolism
13. Cardiovascular risk and chronic kidney disease: strategies for cardiac and renal protection. Interdisciplinary consensus
    Oksana M. Drapkina, Zhanna D. Kobalava, Marina Vladimirovna Shestakova, Irina Nikolaevna Bobkova, Ефремовцева Марина Алексеевна, Виллевальде Светлана Вадимовна, М. М. Batyushin, Yu. N. Belenkov, Andrey Vatazin, Albert S. Galyavich et al. · 2025 · CARDIOVASCULAR THERAPY AND PREVENTION
14. Prevalence of chronic kidney disease in Brazilians with arterial hypertension and/or diabetes mellitus
    Luma de Oliveira Comini, Laura Camargo de Oliveira, Luiza Delazari Borges, Heloísa Helena Dias, Clara Regina Santos Batistelli, Emily de Souza Ferreira, Luciana Saraiva da Silva, Tiago Ricardo Moreira, Glauce Dias da Costa, Rodrigo Gomes da Silva et al. · 2020 · Journal of Clinical Hypertension
15. Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
    Jaehyun Bae, Young Jun Won, Byung‐Wan Lee · 2021 · Life
16. A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
    Hertzel C. Gerstein, Chinthanie F. Ramasundarahettige, A Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Gilles R. Dagenais, Edward Franek, Mark C Lakshmanan, Fernando Tomas Lanas et al. · 2022 · Cardiovascular Diabetology
17. Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis
    Li Zhang, Shuai Xue, Meiyan Wu, Dong Dan · 2022 · Frontiers in Medicine
18. Chronic Kidney Disease Management in Developing Countries
    Danielle A. Badro · 2023 · Springer eBooks
19. The relationship between health literacy and successful aging in elderly individuals with type 2 diabetes
    Merve Kolcu, Elif Bülbül, Selda Gedik Çelik, Gülden Anataca · 2023 · Primary care diabetes
20. Management of Cardiovascular Diseases in Chronic Hemodialysis Patients
    Zhen Zhang, Yaqiong Wang · 2023 · Reviews in Cardiovascular Medicine
21. Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort
    Johannes Ruhe, Jennifer Nadal, Barbara Bärthlein, Heike Meiselbach, Ulla T. Schultheiß, Fruzsina Kotsis, Helena Stockmann, Vera Krane, Claudia Sommerer, Ivonne Loeffler et al. · 2023 · Clinical Kidney Journal
22. Terpenoids in Diabetic Nephropathy: Advances and Therapeutic Opportunities
    Manish Kaushik, Aditi Kaushik, Jasmine Chaudhary, Akash Jain · 2023 · Endocrine Metabolic & Immune Disorders - Drug Targets
23. Bleeding Risk in Hemodialysis Patients
    Anita van Eck van der Sluijs, Pearl Mingchu Pai, Wenjuan Zhu, Gürbey Ocak · 2023 · Seminars in Nephrology
24. A strategic study of acupuncture for diabetic kidney disease based on meta-analysis and data mining
    Yunfeng Yu, Gang Hu, Xinyu Yang, Yuman Yin, Keke Tong, Rong Yu · 2024 · Frontiers in Endocrinology
25. InspeCKD - Analyse zur Nutzung von Labordiagnostik im Kontext der chronischen Nierenerkrankung
    Christoph Wanner, Elke Schäeffner, Thomas Frese, Christoph D. Weber, Philipp Stahl, Felix Scherg, Fabian Burckhardt, Ulrich Opfermann, Frank Radowsky, Frederik M. Mader · 2024 · MMW - Fortschritte der Medizin
26. Plasma Concentrations of Trimethylamine-N-Oxide, Choline, and Betaine in Patients With Moderate to Advanced Chronic Kidney Disease and Their Relation to Cardiovascular and Renal Outcomes
    Rima Obeid, Hussain Mohamad Awwad, Gunnar Henrik Heine, Insa E. Emrich, Danilo Fliser, Adam M. Zawada, Jürgen Geisel · 2024 · Journal of Renal Nutrition
27. Anemia in Elderly Patients: Contribution of Renal Aging and Chronic Kidney Disease
    Simone Santos, Irina Lousa, Márcia C. Carvalho, Maria Sameiro-Faria, Alice Santos‐Silva, Luı́s Belo · 2025 · Geriatrics
28. Associations of endogenous markers of kidney function with outcomes
    Brad C. Astor, Sumaira Shaikh, Muhammad Aslam Chaudhry · 2013 · Current Opinion in Nephrology & Hypertension
29. Diabetische Nierenerkrankung (Update 2026)
    Harald Sourij, Felix Aberer, Marlies Antlanger, Johanna Brix, Daniel Cejka, Martin Clodi, Roland Edlinger, Kathrin Eller, Sabine Horn, Susanne Kaser et al. · 2016 · Wiener klinische Wochenschrift
30. Hyperkalemia in the Hypertensive Patient
    Jay Ian Lakkis, Matthew R. Weir · 2018 · Current Cardiology Reports
31. Sudomotor dysfunction independently predicts incident cardiovascular–renal events and all-cause death in type 2 diabetes: the Joint Asia Diabetes Evaluation register
    Lee‐Ling Lim, Amy W. C. Fu, Eric S. H. Lau, Risa Ozaki, Kitty Kit-Ting Cheung, Ronald C.W., Andrea O. Y. Luk, Juliana C.N. Chan, Alice P.S. Kong · 2018 · Nephrology Dialysis Transplantation
32. Diabetes
    Ian J. Neeland, Kershaw V. Patel · 2018 · Elsevier eBooks
33. Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry
    Christine Gyldenkerne, Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Morten Madsen, Troels Thim, Morten Würtz, Lisette Okkels Jensen, Bent Raungaard, Per Løgstrup Poulsen, Hans Erik Bøtker et al. · 2020 · Diabetes and Vascular Disease Research
34. Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
    Hiroshi Yokomichi, Akiko Nagai, Makoto Hirata, Mie Mochizuki, Reiji Kojima, Zentaro Yamagata, BioBank Japan Project · 2020 · Endocrinology Diabetes & Metabolism
35. Reduced Glomerular Filtration Rate and Risk of Stroke: A Nationwide Cohort Study in South Korea
    Chang‐Mo Oh, Sung Keun Park, Ju Young Jung, Joong‐Myung Choi, Eun‐Hee Ha, Eun-Young Lee, Jung‐Wook Kim, Hee Yong Kang, Hong Jun Yang, Jae‐Hong Ryoo · 2020 · Journal of Atherosclerosis and Thrombosis
36. Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study
    Juan Ignacio Calvo Hueros, María Victoria Martín Hidalgo-Barquero, José Antonio Morales-Gabardino, Francisco Buitrago · 2020 · Primary care diabetes
37. Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial
    Min Jun, Katie Harris, Hiddo J.L. Heerspink, Sunil V. Badve, Meg Jardine, Stephen B. Harrap, Pavel Hamet, Michel Marre, Neil R Poulter, Sradha S. Kotwal et al. · 2021 · Diabetes Obesity and Metabolism
38. The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis
    María Marqués, Paula López Sánchez, Fernando Tornero, Pedro Gargantilla, Alba Maroto, Alberto Ortíz, José María Portolés · 2022 · Clinical Kidney Journal
39. Normoalbuminuric renal impairment and all-cause mortality in type 2 diabetes mellitus
    Salvatore De Cosmo, Olga Lamacchia, Antonio Pacilli, Stefania Fariello, Sabina Pinnelli, Andrea Fontana, Lazzaro Di Mauro, Mauro Cignarelli, Vincenzo Trischitta · 2014 · Acta Diabetologica
40. On the rationale of population screening for chronic kidney disease: a public health perspective
    Murielle Bochud · 2015 · Public health reviews
41. Albuminuria is an independent risk factor of T4 elevation in chronic kidney disease
    Xin Du, Binbin Pan, Wen Li, Yonghua Zou, Xi Hua, Wenjuan Huang, Xin Hua Wan, Changchun Cao · 2017 · Scientific Reports
42. Association between albumin-to-globulin ratio and long-term mortality in patients with chronic kidney disease: a cohort study
    Mengru Zeng, Yu Liu, Fuyou Liu, Youming Peng, Lin Sun, Li Xiao · 2020 · International Urology and Nephrology
43. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate
    Jingya Niu, Xiaoyun Zhang, Mian Li, Shujing Wu, Ruizhi Zheng, Li Chen, Yanan Huo, Min Xu, Tiange Wang, Zhiyun Zhao et al. · 2023 · Diabetes & Metabolism
44. Long-term air pollution exposure, habitual physical activity, and incident chronic kidney disease
    Zhihao Li, Wei-Qi Song, Cheng-Shen Qiu, Hongmin Li, Xu-Lian Tang, Dong Shen, Peidong Zhang, Xiru Zhang, Jiaojiao Ren, Jian Gao et al. · 2023 · Ecotoxicology and Environmental Safety
45. Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter
    Chiara Abenavoli, Michele Provenzano, Sara Helena Ksiazek, Lilio Hu, Vania Cuna, Gaetano La Manna, Giorgia Comai, Olga Baraldi · 2024 · Reviews in Cardiovascular Medicine
46. Associations and attributable burden between risk factors and all-cause and cause-specific mortality at different ages in patients with hypertension
    Qiao Jin, Jie Mei, Y. C. Wong, Cindy Lo Kuen Lam, Eric Yuk Fai Wan · 2024 · Hypertension Research
47. The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials
    Mustafa Arici, Bülent ALTUN, Mustafa Araz, Ayşegül Akın Atmaca, Tevfik Demir, Tevfik Ecder, Galip Güz, Dilek Gogaş Yavuz, Alaattin Yildiz, Temel Yilmaz · 2024 · Frontiers in Medicine
48. Mitochondrial related variants associated with cardiovascular traits
    Marisa Cañadas‐Garre, Joaquín J. Maqueda, Blanca Baños‐Jaime, Claire Hill, Ryan Skelly, Ruaidhri Cappa, Eoin Patrick Brennan, Ross Doyle, Catherine Godson, Alexander Peter Maxwell et al. · 2024 · Frontiers in Physiology
49. Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline
    Sheldon W. Tobe, HARPREET SINGH BAJAJ, Navdeep Tangri, Rahul Jain, Thuy Trang Pham, Valerie Beaudin, Phil McFarlane · 2025 · Canadian Journal of Diabetes
50. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy
    Gemma E. Currie, Christian Delles · 2016 · Current Diabetes Reports
51. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study
    A. Hirata, T. Okamura, D. Sugiyama, K. Kuwabara, A. Kadota, A. Fujiyoshi, K. Miura, N. Okuda, T. Ohkubo, A. Okayama et al. · 2017 · European Journal of Preventive Cardiology
52. The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary?
    Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia · 2018 · Journal of Nephrology
53. Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
    Zhenzhen Rao, Hongqiu Gu, Xianwei Wang, Xuewei Xie, Xin Yang, Chun‐Juan Wang, Xingquan Zhao, Ying Xian, Yilong Wang, Zi‐Xiao Li et al. · 2019 · Journal of the American Heart Association
54. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes
    Richard L. Sheer, Radhika Nair, Margaret K. Pasquale, Thomas Evers, Meghan M. Cockrell, Alain Gay, Rakesh Singh, Niklas Schmedt · 2022 · Journal of Primary Care & Community Health
55. Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome
    Vincenzo Livio Malavasi, Anna Chiara Valenti, Sara Ruggerini, Marcella Manicardi, Carlotta Orlandi, Daria Sgreccia, Marco Vitolo, Marco Proietti, Gregory Y.H. Lip, Giuseppe Boriani · 2022 · Journal of Clinical Medicine
56. Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease
    Michele Provenzano, Federica Maritati, Chiara Abenavoli, Claudia Bini, Valeria Corradetti, Gaetano La Manna, Giorgia Comai · 2022 · International Journal of Molecular Sciences
57. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2
    Yoshiteru Maeda, Atsushi Suzuki, Junnichi Ishii, Sahoko Sekiguchi-Ueda, Megumi Shibata, Yasumasa Yoshino, S Asano, Nobuki Hayakawa, Kazuhiro Nakamura, Yasukazu Akiyama et al. · 2014 · Heart and Vessels
58. Direct renin inhibition in chronic kidney disease
    Frederik Persson, Peter R Rossing, HANS-HENRIK D. PARVING · 2012 · British Journal of Clinical Pharmacology
59. Clinical Considerations for the Association between Vascular Damage and Chronic Kidney Disease
    Hirofumi Tomiyama, Akira Yamashina · 2014 · Pulse
60. Chronic Kidney Disease As a Potential Indication for Renal Denervation
    Margreet F. Sanders, Peter J. Blankestijn · 2016 · Frontiers in Physiology
61. Risk for acute kidney injury in primary health care
    Maria Célia Laranjeira Rigonatto, Márcia Cristina da Silva Magro · 2017 · Revista Brasileira de Enfermagem
62. Association of renal hyperfiltration with incident proteinuria - A nationwide registry study
    Seung Min Lee, Ju-Young Park, Min-Su Park, Jong Heon Park, Minseon Park, Hyung‐Jin Yoon · 2018 · PLoS ONE
63. Abelmoschus manihot for Diabetic Nephropathy: A Systematic Review and Meta-Analysis
    Liwei Shi, Ling Feng, Meizhen Zhang, Xiaowen Li, Yanan Yang, Yueying Zhang, Qing Ni · 2019 · Evidence-based Complementary and Alternative Medicine
64. The Influence of Processing and Storage Conditions on Renal Protein Biomarkers
    Callen D. Giesen, John Charles Lieske · 2016 · Clinical Journal of the American Society of Nephrology
65. Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013–2019
    Wang, Eric, Patorno, Elisabetta, Khosrow-Khavar, Farzin, Crystal, Stephen, Dave, Chintan V. · 2025 · Diabetologia
66. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk
    Böhm, Michael, Schumacher, Helmut, Teo, Koon K., Lonn, Eva M., Mahfoud, Felix, Emrich, Insa, Mancia, Giuseppe, Redon, Josep, Schmieder, Roland E., Sliwa, Karen et al. · 2021 · Journal of Hypertension
67. Finerenone in diabetic kidney disease: a new frontier for slowing disease progression
    Ibrahim S. Alhomoud, Mohamed A. Albekery, Razan Alqadi, Amal Alqumia, Riaz A. Khan, Muthana A. Al Sahlawi, Mohammed Yousef Al Mulhim · 2025 · Frontiers in Medicine
68. Omega 3 fatty acids effect on the vascular calcification biomarkers fetuin A and osteoprotegerin in hemodialysis patients
    Rehab H. Werida, Sohaila Abou-Madawy, Mohamed Said Abdelsalam, Maged W. Helmy · 2021 · Clinical and Experimental Medicine
69. Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages
    Seng-Wei Ooi, Shu‐Tin Yeh, Ya‐Hui Chang, Chung‐Yi Li, Hua-Fen Chen · 2022 · PLoS ONE
70. Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology
    Tomasz P. Stompór, Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Michal P. Nowicki, Leszek Tylicki, Agata Winiarska, Magdalena Krajewska · 2023 · Journal of Clinical Medicine
71. Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria
    Stein Ivar Hallan, Marius Altern Øvrehus, Manjula Darshi, Daniel Montemayor, Knut Asbjørn Rise Langlo, Per Bruheim, Kumar Sharma, the CRIC Study Investigators · 2023 · Kidney360
72. Cardio‐renal‐metabolic disease in primary care setting
    Mahmoud Ashraf Ibrahim, Ebtesam M. Ba-Essa, Jason C. Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H. Eckel, Luc Van Gaal, Peter Gæde et al. · 2023 · Diabetes/Metabolism Research and Reviews
73. Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease
    Christine P. Limonte, Julio Alejandro Lamprea-Montealegre, Katherine R. Tuttle · 2024 · Seminars in Nephrology
74. Both Chronic Kidney Disease and Nocturnal Blood Pressure Associate with Strokes in the Elderly
    Yuichiro Yano, George L. Bakris, Kunihiro Matsushita, Satoshi Hoshide, Kazuyuki Shimada, Kazuomi Kario · 2013 · American Journal of Nephrology
75. N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
    Marit Dahl Solbu, Ingrid Toft, Maja‐Lisa Løchen, Ellisiv Bøgeberg Mathiesen, Björn O. Eriksen, Toralf Melsom, Inger Njølstad, Tom Wilsgaard, Trond Geir Jenssen · 2015 · Journal of the American Society of Nephrology
76. Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis
    Yong Zeng, Danwen Yang, Sheng Feng, Huaying Shen, Z. Wang, Shan Jiang, Yong Shi, Jinxiang Fu · 2016 · Brazilian Journal of Medical and Biological Research
77. Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data
    Iryna Schlackow, C. Simons, Jason Lee Oke, Benjamin G. Feakins, Christopher A. O’Callaghan, Richard F. Hobbs, Daniel S Lasserson, Richard Stevens, Rafael Perera, Borislava Mihaylova · 2020 · PLoS Medicine
78. Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches
    Nabil Foudi, Maeva Palayer, Marie B Briet, Anne‐Sophie Garnier · 2021 · Journal of Clinical Medicine
79. Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients
    V. Arcoraci, M. A. Barbieri, M. Rottura, A. Nobili, G. Natoli, C. Argano, G. Squadrito, F. Squadrito, S. Corrao · 2021 · Frontiers in Pharmacology
80. The Effects of Dipeptidyl Peptidase 4 Inhibitors on Renal Function in Patients with Type 2 Diabetes Mellitus
    Wan-Chia Hsu, Chunsheng Lin, Jung‐Fu Chen, Chih‐Min Chang · 2022 · Journal of Clinical Medicine
81. Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
    Luca De Nicola, Mario Gennaro Cozzolino, Simonetta Genovesi, Loreto Gesualdo, Giuseppe Grandaliano, Roberto Pontremoli · 2022 · Journal of Nephrology
82. Social determinants of incidence, outcomes, and interventions of cardiovascular disease risk factors in American Indians and Alaska Natives
    Eric Leung, Tassy Parker, Allyson Kelley, James C. Blankenship · 2022 · World Medical & Health Policy
83. Comparison of CROES, S.T.O.N.E, and Guy’s scoring systems for the prediction of stone-free status and complication rates following percutaneous nephrolithotomy in patients with chronic kidney disease
    Fatih Yanaral, Faruk Özgör, Metin Savun, Murat Sahan, Ömer Sarılar, Murat Binbay · 2017 · International Urology and Nephrology
84. Novel differences in renal gene expression in a diet-induced obesity model
    Victoria L. Halperin Kuhns, Jennifer L. Pluznick · 2017 · American Journal of Physiology-Renal Physiology
85. Estimated Glomerular Filtration Rate, Proteinuria, and Risk of Cardiovascular Diseases and All-cause Mortality in Diabetic Population: a Community-based Cohort Study
    Anxin Wang, Guojuan Chen, Yibin Cao, Xiaoxue Liu, Zhaoping Su, Yanxia Luo, Zhanzheng Zhao, Xia Li, Shuohua Chen, Shouling Wu et al. · 2017 · Scientific Reports
86. Association of Diet Quality Indices with Longitudinal Changes in Kidney Function in U.S. Hispanics/Latinos: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
    Celestin Missikpode, Ana Catherine Ricardo, Ramón Durazo-Arvizú, Anjella Manoharan, Josiemer Mattei, Carmen R. Isasi, Yasmin Mossavar‐Rahmani, Gregory A. Talavera, Daniela Sotres‐Alvarez, Martha L. Daviglus et al. · 2020 · Kidney360
87. Pulse Wave Velocity as a Marker of Vascular Dysfunction and Its Correlation with Cardiac Disease in Children with End-Stage Renal Disease (ESRD)
    Cristina Iulia Filip, Catalin Gabriel Cirstoveanu, Mihaela Bizubac, Camelia Elena Berghea, Andrei Căpitănescu, Mihaela Bălgrădean, Carmen Pavelescu, Alin Marcel Nicolescu, Marcela Daniela Ionescu · 2021 · Diagnostics
88. Predictors Associated with Type 2 Diabetes Mellitus Complications over Time: A Literature Review
    Marwa Elsaeed Elhefnawy, Siti Maisharah Sheikh Ghadzi, Sabariah Noor Harun · 2022 · Journal of Vascular Diseases
89. Contrasting Effects of Systemic Monocyte/Macrophage and CD4+T Cell Depletion in a Reversible Ureteral Obstruction Mouse Model of Chronic Kidney Disease
    Lee Daniel Chaves, Liby Mathew, Mohammed I. Shakaib, Anthony Chang, Richard John Quigg, Tipu S. Puri · 2013 · Clinical and Developmental Immunology
90. Poor risk factor control in outpatients with diabetes mellitus type 2 in Germany: The DIAbetes COhoRtE (DIACORE) study
    Myriam Rheinberger, Bettina Jung, Thomas Segiet, J. Nusser, Günther Kreisel, Axel Andreae, Jochen Manz, Gerhard Haas, Bernhard Banas, Klaus J. Stark et al. · 2019 · PLoS ONE
91. Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study
    David Collins. Wheeler, Kevin M. Pantalone, Lixin Guo, Nihar R. Desai, Ricardo Correa‐Rotter, Susanne B. Nicholas, Nan Hee Kim, Zihe Zheng, Charlie A. B. Scott, Andrea Horvat-Broecker et al. · 2025 · Clinical Kidney Journal
92. Validation of the kidney failure risk equation in a Portuguese cohort
    Bernardo Marques da Silva, José Charreu, Inês Duarte, Cristina Outerelo, Joana Gameiro · 2022 · Nefrología (English Edition)
93. Subtypes of Type 2 Diabetes and Incident Cardiovascular Disease Risk: UK Biobank and All of Us Cohorts
    Qiaochu Xue, Xiang Li, Xuan Wang, Hao Ma, Yoriko Heianza, Lu Qi · 2023 · Mayo Clinic Proceedings
94. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure
    Valeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, Chiara Casuscelli, Silvia Di Carlo, Claudia Spinella, Guido Gembillo, Domenico Santoro · 2023 · Expert Opinion on Pharmacotherapy
95. Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes
    Jocelyn Cervantes, Juraj Koška, Farah Kramer, Shreeram Akilesh, Charles E. Alpers, Adam E. Mullick, Peter D. Reaven, Jenny E. Kanter · 2024 · JCI Insight
96. Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: The Taichung Diabetes Study
    Cheng‐Chieh Lin, Ching‐Chu Chen, Pei‐Tseng Kung, Chia-Ing Li, Sing-Yu Yang, Chiu-Shong Liu, Wen‐Yuan Lin, Cheng-Chun Lee, Tsai‐Chung Li, Sharon L. R. Kardia · 2012 · Cardiovascular Diabetology
97. Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline
    Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Carlos Gabriel Grijalva, Xulei Liu, Harvey J. Murff, Talat Alp Ikizler, Marie R. Griffin · 2016 · Clinical Journal of the American Society of Nephrology
98. PHLPP1/Nrf2–Mdm2 axis induces renal apoptosis via influencing nucleo-cytoplasmic shuttling of FoxO1 during diabetic nephropathy
    Alpana Mathur, Vivek Kumar Pandey, Mohammad Fareed Khan, Poonam Kakkar · 2021 · Molecular and Cellular Biochemistry
99. National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
    Murphy Murphy · 2021 · The Journal of Family Practice
100. Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease
     Wojciech Knop, Natalia Maria Serwin, Elżbieta Cecerska‐Heryć, Bartłomiej Grygorcewicz, Barbara Dołęgowska, Aleksandra Gomółka, Magda Wiśniewska, Kazimierz Ciechanowski · 2021 · Biomolecules